A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, ...

A panelist discusses how novel targeted therapies such as antibody-drug conjugates are rapidly evolving in gynecologic ...

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder ...

The Trump administration has decided to further debate the federal rule passed during the Biden administration that ...

Second of 2 parts featuring an interview with Stephen Strickland, MD, MSCI,director, Leukemia Research for Sarah Cannon ...

Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, seem to align with recent bad news for this ...

Proposed Medicaid cuts in the Republican budget proposal hold significant implications for health care access and coverage.

Researchers hope that identifying the genomic alterations specific to transformed small cell lung cancer (SCLC) can help ...

Across various classes, the researchers identified a model that, when coupled with appropriate data augmentation and ...

The analysis of 3 dozen studies found similarities and differences in motivating factors for and against clinical trial ...

Upadacitinib shows sustained efficacy and consistent safety for moderate to severe ulcerative colitis in long-term trials and ...

Multidisciplinary efforts help promote the success of clinical trials and innovation for patients with various forms of ...